BNGO/ News und Infos Forum: Community User: Ray7

https://seekingalpha.com/article/4411122-illuminas-buzzing-genome-market

https://finance.yahoo.com/news/bionano-customer-praxis-genomics-receives-140700623.html

Newsletter gerade bekommen

https://ir.bionanogenomics.com/single-news-releases/?storyid=6904821381998800

Bionano’s Saphyr Data Prove Essential in Creating the Most Comprehensive, Ethnically Diverse Collection of Genome Variation Ever Completed globenewswire | 25.02.2021 | 22:30 Article published in Science reveals that optical genome mapping uniquely makes thousands of large structural variant calls SAN DIEGO, Feb. 25, 2021 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) announced the publication in Science of a study by the Human Genome Structural Variation Consortium (HGSVC) that used a combination of advanced sequencing and optical genome mapping (OGM) with Saphyr to assemble with high resolution and structural accuracy 64 haplotype-resolved human genomes from 32 individuals representing 25 different populations. The peer-reviewed publication, which previously appeared on the pre-print server bioRxiv, builds on the original Human Genome Project to better capture genetic diversity by cataloging both single nucleotide variations (SNVs) and structural variations (SVs) from each individual reference-quality genome assembly compared to the standard human genome reference. The resulting assemblies and catalog of SNVs and SVs can serve as a diversity panel that researchers and clinicians can use to accelerate the discovery of new therapeutic targets and pathogenic genetic variations by making it easier and faster to filter out variation that is representative of population diversity. They further enable population-specific studies on genetic predispositions to human diseases as well as the potential discovery of more complex forms of genetic variation.

Das stimmt... Hab ich am 25.01 gepostet😉 Ganz oben.

Anstehende Termine für BIONANO GENOMICS, INC.18.03.21 FY 2020 Earnings Release (Projected) 13.05.21 Q1 2021 Earnings Release (Projected) 12.08.21 Interim 2021 Earnings Release (Projected) 11.11.21 Q3 2021 Earnings Release (Projected)

Hab in einem Forum gelesen das am 18.03.2021 BNGO seine Quartalszahlen zum 4. Quartal 2020 vorlegt. Ray, stimmt das?

Bionano Publishes Method for Identifying Genes Likely to Cause Neurological Diseases Based on a Model Developed by Lineagen to Improve Interpretation of Variants of Unknown Significance globenewswire | 22.02.2021 | 14:00 Proprietary scoring algorithm may help identify novel genes for nervous system disorders; applications include patient testing and eventually discovery research with Saphyr SAN DIEGO, Feb. 22, 2021 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) announced the publication of a study by its Lineagen team that describes the first genome-wide model to assess and score nearly all protein-coding genes based on their likelihood to cause central nervous system (CNS) disease. The resulting list of high scoring genes enhances Lineagen’s clinical interpretation capabilities allowing their genetic counsellors to better interpret variants of unknown significance (VUS), which can improve diagnostic abilities and provide for more precise counseling to patients and families. The gene scoring model can also be integrated into Bionano’s analysis software for Saphyr data, allowing scientists and clinicians to quickly identify and filter structural variants based on their increased risk of causing CNS diseases.

Resolve structural variations missed by next-generation sequencing (NGS) and cytogenetic systems Structural variations are responsible for many diseases and conditions, including cancers and developmental disorders. Saphyr detects structural variations and chromosomal abnormalities ranging from 500 bp to megabase pairs in length and offers assembly and discovery algorithms that far outperform sequencing-based technologies in sensitivity. 99% sensitivity for homozygous insertions/deletions larger than 500 base pairs 95% sensitivity for heterozygous insertions/deletions larger than 500 base pairs 95% sensitivity for balanced and unbalanced translocations larger than 50,000 base pairs 99% sensitivity for inversions larger than 30,000 base pairs 97% sensitivity for duplications larger than 30,000 base pairs 97% sensitivity for copy number variants larger than 500,000 base pairs

REAGENT RENTAL AGREEMENT Run samples in-house with a Saphyr® Instrument free of charge for the duration of your project. The Bionano Support team will install the Saphyr System and provide training on sample preparation, instrument operation, and data analysis. Pricing $550 per genome with commitment of 120 genomes per 6 months (includes DNA isolation, labeling, chips and Bionano Compute On Demand) Installation and training included

Pricing Saphyr System starting at $150,000 $550 per genome $450 per genome with 240 genome bundle Installation and training included

Magst du die 3 mit uns teilen bzw. uns mitteilen, Ray?

Nr. 1 Lauf motley fool💹💹💹 https://www.fool.de/2021/02/14/3-aktien-die-in-3-monaten-200-000-euro-in-ueber-1-million-euro-verwandelt-haben/